Profile: W.H.P.M., Inc. deals with rapid test systems. Our current product leader is Hemosure®, a trade name recognized worldwide in immunological fecal occult blood test (IFOBT). The Hemosure® one-step immunological fecal occult blood test is a qualitative, sandwich dye conjugate immunoassay that employs a unique combination of monoclonal and polyclonal antibodies to selectively identify hemoglobin in test samples with a high degree of sensitivity. The elevated levels of human hemoglobin as low as 0.05µgHb/ml can be detected in less than 5 minutes. The positive results for high levels of hemoglobin can be seen in the test as early as one or two minutes. The First Sign™ one-step drug of abuse test is a one-step membrane immuno-chromatographic test based on antigen/antibody complexation. It is used for the analysis of abused drug and its metabolites present in the test sample. The assay is based on the competition between the drug or drug metabolite in the sample and a drug conjugate immobilized on a porous membrane support for limited antibody sites on the colored microspheres.
The company was founded in 1992.
FDA Registration Number: 3005345870
US Agent: Fran White / Mdc Associates, Llc
Phone: +1-(978)-927-3808 Fax: +1-(978)-927-1308 E-Mail:
46 Products/Services (Click for related suppliers)
|
• Amphetamine Enzyme Immunoassay Test (FDA Code: DKZ / 862.3100) An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy. |
• Amphetamine Test Cassettes |
• Amphetamine Urine Dip Strip Test |
• Barbiturate Enzyme Immunoassay Test (FDA Code: DIS / 862.3150) A barbiturate test system is a device intended to measure barbiturates, a class of hypnotic and sedative drugs, in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of barbiturate use or overdose and in monitoring levels of barbiturate to ensure appropriate therapy. |
• Barbiturate Test Dip Cards |
• Barbiturate Urine Cassette Test |
• Benzodiazepine Enzyme Immunoassay Test (FDA Code: JXM / 862.3170) A benzodiazepine test system is a device intended to measure any of the benzodiazepine compounds, sedative and hypnotic drugs, in blood, plasma, and urine. The benzodiazepine compounds include chlordiazepoxide, diazepam, oxazepam, chlorzepate, flurazepam, and nitrazepam. Measurements obtained by this device are used in the diagnosis and treatment of benzodiazepine use or overdose and in monitoring levels of benzodiazepines to ensure appropriate therapy. |
• Cocaine and Cocaine Metabolites Enzyme Immunoassay Test (FDA Code: DIO / 862.3250) A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose. |
• Cocaine Test Cassettes |
• Cocaine Test Strip |
• Cocaine Urine Dip Strip Test |
• Diagnostic Test Kits For Pregnancy |
• Drugs Of Abuse Test Kits |
• Fecal Occult Blood Test |
• Fecal Occult Blood Test Kits |
• HCG Over The Counter Pregnancy Test Kit (FDA Code: LCX / 862.1155) A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine. |
• Hcg Pregnancy Test Strip |
• Human Chorionic Gonadotropin Radioimmunoassay (FDA Code: JHI / 862.1155) |
• Immunoassay Systems |
• Immunoassays |
• Metamphetamine Thin Layer Chromatography Test (FDA Code: DJC / 862.3610) A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose. |
• Methadone Enzyme Immunoassay Test (FDA Code: DJR / 862.3620) A methadone test system is a device intended to measure methadone, an addictive narcotic pain-relieving drug, in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of methadone use or overdose and to determine compliance with regulations in methadone maintenance treatment. |
• Methadone Test Cassettes |
• Methadone Test Dip Cards |
• Methadone Test Strip |
• Methamphetamine Gas Chromatography Test (FDA Code: LAF / 862.3610) |
• Methamphetamine Urine Dip Strip Test |
• Morphine Card Test |
• Morphine Urine Drug Test |
• Occult Blood Reagent (FDA Code: KHE / 864.6550) An occult blood test is a device used to detect occult blood in urine or feces. (Occult blood is blood present in such small quantities that it can be detected only by chemical tests of suspected material, or by microscopic or spectroscopic examination.) |
• Opiates Enzyme Immunoassay Test (FDA Code: DJG / 862.3650) An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy. |
• Ovulation Test |
• Ovulation Test Device (Urine) |
• Ovulation Test Strip (Urine) |
• Ovulation-Prediction Testing Kits |
• Oxycodone Test Cassettes |
• Phencyclidine Enzyme Immunoassay (FDA Code: LCM) |
• Phencyclidine Test Dip Cards |
• Phencyclidine Urine Cassette Test |
• Pregnancy Test Device (Urine) |
• Pregnancy Test Kit |
• Pregnancy Testing Kits |
• Pregnancy Urine Card Test |
• Saliva Testing |
• Tetrahydrocannabinol Test (FDA Code: DKE / 862.3870) A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds includedelta -9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use. |
• Tricyclic Antidepressant Drugs Radioimmunoassay Test (FDA Code: LFG / 862.3910) A tricyclic antidepressant drugs test system is a device intended to measure any of the tricyclic antidepressant drugs in serum. The tricyclic antidepressant drugs include imipramine, desipramine, amitriptyline, nortriptyline, protriptyline, and doxepin. Measurements obtained by this device are used in the diagnosis and treatment of chronic depression to ensure appropriate therapy. |